# Società Italiana di Medicina Interna: Observational study in Atrial Fibrillation (AF), Major Gastrointestinal Bleeding (MGIB) (650 participants)

**Score:** 55/100

| Field | Value |
|---|---|
| Sponsor | Società Italiana di Medicina Interna |
| Sponsor type | Academic and hospital |
| Study | Resumption of Anticoagulation After Major Gastrointestinal Bleeding in Patients With Atrial Fibrillation |
| NCT ID | NCT07901699 |
| Phase | Observational |
| Status | active not recruiting |
| Conditions | Atrial Fibrillation (AF); Major Gastrointestinal Bleeding (MGIB) |
| Target enrollment | 650 |
| Site countries | Italy |
| Posted | 2026-10-28 |
| Planned start | 2024-01-05 |
| Event | Newly registered study |
| Event date | 2026-10-28 |

## Why this score
- Posted in the last two weeks.
- 650 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07901699). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.